Choong-wae announces development of anticancer agent to kill leukemia stem cells

Published: 2010-04-23 06:57:00

Updated: 2010-04-23 06:57:00

Choong-wae Pharm announced on April 19 the development of an anti-cancer medicine that interrupts biochemical signals to eradicate leukemia stem cells without affecting normal cells.

Speaking at a seminar at the American Association of Cancer Research, Kathy Emami (photo), a research fellow of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK